Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations
about
Assessing the Efficacy of Lopinavir/Ritonavir-Based Preferred and Alternative Second-Line Regimens in HIV-Infected Patients: A Meta-Analysis of Key Evidence to Support WHO Recommendations
description
article
@en
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@en
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@nl
type
label
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@en
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@nl
prefLabel
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@en
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@nl
P2093
P2860
P356
P1476
Assessing the Efficacy of Lopi ...... to Support WHO Recommendations
@en
P2093
Aixin Song
Xiaojie Huang
Xingbao Tao
Yadong Luo
Yaokai Chen
Yihong Zhou
Yinqiu Huang
P2860
P356
10.3389/FPHAR.2018.00890
P407
P577
2018-01-01T00:00:00Z